The major vendors ratcheted things up a notch in the radiography and fluoroscopy (R/F) arena, focusing on total interventional solutions and specific enhancements, including improved dose control, during the 2004 RSNA scientific meeting.
The major vendors ratcheted things up a notch in the radiography and fluoroscopy (R/F) arena, focusing on total interventional solutions and specific enhancements, including improved dose control, during the 2004 RSNA scientific meeting.
GE Healthcare launched its Interventional Suite, featuring the OEC 9800 MD digital motorized mobile imaging system. The system includes ceiling-supported monitors, four-way floating imaging tables, and contrast injectors.
Siemens Medical Solutions received 510(k) clearance for DynaCT, an enhancement for its C-arm angiography systems that allows soft-tissue imaging. The upgrade is touted as the first application that enables angiographic CT.
On the general-purpose R/F side, Philips' EasyDiagnost Eleva was shown with CR integration, enabling customers to fully digitize their R/F suites.
GE Healthcare provides medical technologies designed to improve patient care, with expertise in medical imaging and information technologies, medical diagnostics, and patient monitoring systems to detect disease early and tailor treatment to individual patients.
The company has a 20-year history of developing digital medical imaging solutions. This year, Infimed introduced a new series of cardiology products based on its PlatinumOne in-room digital acquisition platform designed to support complex interventional procedures.
Philips competes with GE and Siemens for market leadership in various areas of medical diagnostic imaging.
Siemens is an imaging leader with a reputation for consistency. Its solutions range from imaging systems and therapy equipment to electromedical and instruments.
Thales designs and manufactures CCD cameras for radiological applications.
Toshiba markets, sells, distributes, and services diagnostic imaging systems, while coordinating clinical diagnostic imaging research for all modalities in the U.S. The company is a global provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, x-ray, ultrasound, nuclear medicine, and MRI systems.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.